Kavanaugh, A., Krueger, G., Beutler, A., Guzzo, C., Zhou, B., Dooley, L., ...
To evaluate the efficacy and safety of infliximab through 1 year in patients with psoriatic arthritis (PsA) enrolled in the IMPACT 2 trial.Methods: In this double blind, placebo controlled, phase III...
Kavanaugh, A., Krueger, G., Beutler, A., Guzzo, C., Zhou, B., Dooley, L., ...
To evaluate the efficacy and safety of infliximab through 1 year in patients with psoriatic arthritis (PsA) enrolled in the IMPACT 2 trial.Methods: In this double blind, placebo controlled, phase III...
Kavanaugh, A., Krueger, G., Beutler, A., Guzzo, C., Zhou, B., Dooley, L., ...
To evaluate the efficacy and safety of infliximab through 1 year in patients with psoriatic arthritis (PsA) enrolled in the IMPACT 2 trial.Methods: In this double blind, placebo controlled, phase III...
Kavanaugh, A, Antoni, C, Krueger, GG, De Vlam, K, Birbara, C, Beutler, A, ...
Univ Calif San Diego, La Jolla, CA 92093 USA. Univ Erlangen Nurnberg, Erlangen, Germany. Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA. Univ Limburg, Diepenbeek, Belgium. Univ Hosp Maastricht,...
Kavanaugh, A, Antoni, CE, Krueger, GG, Gladman, D, Birbara, C, Boling, EP, ...
Univ Calif San Diego, La Jolla, CA 92093 USA. Univ Erlangen Nurnberg, Erlangen, Germany. Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA. Toronto Western Hosp, Toronto, ON M5T 2S8, Canada. Univ...
Kavanaugh, A, Antoni, CE, Krueger, GG, De Vlam, K, Birbara, C, Beutler, A, ...
Univ Calif San Diego, La Jolla, CA 92093 USA. Univ Erlangen Nurnberg, Erlangen, Germany. Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA. Limburgs Univ Ctr, Diepenbeek, Belgium. Univ Hosp,...
Kavanaugh, A, Antoni, CE, Krueger, GG, Gladman, D, Birbara, C, Boling, EP, ...
Univ Calif San Diego, La Jolla, CA 92093 USA. Univ Erlangen Nurnberg, Erlangen, Germany. Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA. Toronto Western Hosp, Toronto, ON M5T 2S8, Canada. Univ...
Kavanaugh, A, Antoni, CE, Krueger, GG, De Vlam, K, Birbara, C, Beutler, A, ...
Univ Calif San Diego, La Jolla, CA 92093 USA. Univ Erlangen Nurnberg, Erlangen, Germany. Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA. Limburgs Univ Ctr, Diepenbeek, Belgium. Univ Hosp,...
Factors associated with fatigue in patients with systemic lupus erythematosus
Bruce, I., Mak, V., Hallett, D., Gladman, D., Urowitz, M.
OBJECTIVE—To examine the relation between fatigue, disease activity, damage, and quality of life measures in patients with systemic lupus erythematosus (SLE). METHODS—Consecutive patients...
Feletar, M, Brockbank, J, Schentag, C, Lapp, V, Gladman, D
Objective: To evaluate the effectiveness and toxicity of infliximab in patients with recalcitrant psoriatic arthritis (PsA).
Biggar, W. D., Crawford, L., Cardella, C., Bear, R. A., Gladman, D., Reynolds, W. J.
Malakoplakia is a chronic granulomatous inflammatory disorder. It is suspected clinically by the presence of chronic infection and diagnosed by histologic examination of affected tissues. Studies of...
Aberrations in lymphocyte subpopulations and function during psychological stress.
Dorian, B, Garfinkel, P, Brown, G, Shore, A, Gladman, D, Keystone, E
Eight trainees in psychiatry taking their final oral fellowship examinations were compared with 16 controls to determine the effect of stress on their immune system. Two measures of stress were...
Impaired antigen-specific suppressor cell activity in patients with systemic lupus erythematosus.
Gladman, D, Keystone, E, Urowitz, M, Cane, D, Poplonski, L
Antigen-specific suppressor cell activity of peripheral blood mononuclear cells was investigated in twenty-nine patients with systemic lupus erythematosus (SLE) and sixteen normal, age- and...
Enhanced delayed hypersensitivity skin test reactivity with serial testing in healthy volunteers.
Keystone, E C, Demerieux, P, Gladman, D, Poplonski, L, Piper, S, Buchanan, R
Delayed hypersensitivity skin testing with multiple antigens is frequently used to evaluate immunopotentiation therapy in man. Since serial skin testing with a single antigen has been shown to...
Long term treatment of psoriatic arthritis with infliximab
Yazdani-Biuki, B, Wohlfahrt, K, Mulabecirovic, A, Mueller, T, Hermann, J, Graninger, W, ...
Dactylitis in psoriatic arthritis: a marker for disease severity?
Brockbank, J, Stein, M, Schentag, C, Gladman, D
Aim: To describe dactylitis in a large cohort of patients with psoriatic arthritis followed prospectively in a specialist clinic, and identify whether it is associated with a worse prognosis.
Psoriatic arthritis imaging: a review of scoring methods
Sharp, J, Wassenberg, S, Gladman, D
Structural damage assessed on conventional radiographs is an important outcome measure in psoriatic arthritis. This article reviews the available scoring methods. A full description of the methods is...
Discussion: Assessment of psoriatic arthritis
Mease, P, Behrens, F, Boehncke, W, Feldman, S, FitzGerald, O, Gladman, D, ...
OMERACT 7 psoriatic arthritis workshop: synopsis
Gladman, D, Strand, V, Mease, P, Antoni, C, Nash, P, Kavanaugh, A
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
Gladman, D, Antoni, C, Mease, P, Clegg, D, Nash, P
Psoriatic arthritis (PsA) has been defined as a unique inflammatory arthritis associated with psoriasis. Its exact prevalence is unknown, but estimates vary from 0.3% to 1% of the population. The...
Psoriatic arthritis assessment tools in clinical trials
Mease, P, Antoni, C, Gladman, D, Taylor, W
In order to measure disease activity, progression, and change with therapy in psoriatic arthritis (PsA), it is important to use accurate, reliable, and feasible outcome measures that can ideally be...
Autoantibodies in biological agent naive patients with psoriatic arthritis
Johnson, S, Schentag, C, Gladman, D
Objective: To investigate the prevalence of autoantibodies in biological agent naive patients with psoriatic arthritis (PsA).
Association of SEEK1 and psoriatic arthritis in two distinct Canadian populations
Rahman, P, Butt, C, Siannis, F, Farewell, V, Peddle, L, Pellett, F, ...
Methods: 103 patients with PsA and 105 ethnically matched controls from Newfoundland and 202 patients with PsA and 100 controls from Ontario were studied. Patients and controls were genotyped for SNP...
Non-Hodgkin's lymphoma in systemic lupus erythematosus
Bernatsky, S, Ramsey-Goldman, R, Rajan, R, Boivin, J, Joseph, L, Lachance, S, ...
Objectives: To describe demographic factors, subtypes, and survival of patients with SLE who develop NHL.